Matthew Rafferty

Matthew Rafferty has a diverse background in automation engineering and research associate roles. In their most recent position as a Senior Automation Engineer at Prime Medicine, Inc. starting in June 2022, they are responsible for automation processes.

Prior to that, Matthew worked at Genocea from November 2019 to June 2022 as an Automation Engineer. In this role, they managed equipment for clinical research, oversaw preventative maintenance of various equipment, and optimized the existing ATLAS platform through scripting and strategic planning.

Before Genocea, Matthew held the position of Senior Research Associate HT Protein Optimization at Bayer Crop Science from August 2018 to September 2019. Matthew collaborated with project managers and teams, prioritized testing, and led the Protein Production Transition Team.

Matthew's extensive work experience also includes roles at Monsanto Company from November 2007 to August 2018. Matthew served as a Senior Research Associate and Research Associate in protein expression, characterization, and optimization. In addition, they led the Automation Sub Team, worked on developing improved processes, and coordinated the evaluation and implementation of automated liquid handlers.

Overall, Matthew Rafferty has a strong background in automation engineering, research, and optimization, with a focus on improving efficiency and implementing strategic plans.

Matthew Rafferty earned their Bachelor's Degree in Chemical Engineering from Northwestern University, completing their education between 2003 and 2007.